Physician
General Surgery
Dr. Goran B. Klintmalm, MD
|
|
Give Review
Goran Klintmalm works in the field of General Surgery. He received 1 awards: "Fellow (FACS)". Goran Klintmalm has written publications. He has 78 publications published with PubMed. The lastest paper is: 'Surgical treatment of hepatocellular carcinoma in north america: can hepatic resection still be justified?' He accepts Medicare.
Publications
- Surgical treatment of hepatocellular carcinoma in north america: can hepatic resection still be justified?
- Skin cancer evaluation in transplant patients: a physician opinion survey with recommendations.
- Posttransplant lymphoproliferative disorder presenting as a small bowel obstruction in a patient with pancreas transplantation alone.
- Ratio of hepatic arterial flow to recipient body weight predicts biliary complications after deceased donor liver transplantation.
- The Role of Mammalian Target of Rapamycin Inhibitors in the Management of Posttransplant Malignancy.
- Donor-specific alloantibodies are associated with fibrosis progression after liver-transplantation in HCV-infected patients.
- Segmental Biliary Duct N-Butyl Cynaoacrylate ablation in a Transplant liver for a biliary leak after hepaticojejunostomy.
- Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity.
- De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients.
- Impact of donor-specific antibodies on results of liver transplantation.
- Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
- Sirolimus and cardiovascular disease risk in liver transplantation.
- Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation.
- Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.
- Renal-sparing regimens employing new agents.
- Implications of a positive crossmatch in liver transplantation: A 20-year review.
- A randomized multicenter study comparing steroid-free and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
- Effect of tacrolimus on survival in hepatitis C-infected patients after liver transplantation.
- Long-Term Follow-Up of Liver Transplantation for Budd-Chiari Syndrome With Antithrombotic Therapy Based on the Etiology.
- Malpositioned transjugular intrahepatic portosystemic shunt in the common hepatic duct leading to biliary obstruction and liver transplantation.
- A Meta-analysis for Comparison of the Two-Layer and University of Wisconsin Pancreata Preservation Methods in Islet Transplantation:
- One hundred human pancreatic islet isolations at Baylor Research Institute.
- YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study.
- Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
- Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up.
- Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis.
- Whole-organ pancreas transplantation at Baylor Regional Transplant Institute: a chance to cure diabetes.
- Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis.
- Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation.
- Inferior vena cava stent resolves hepatopulmonary syndrome in an adult with a spontaneous inferior vena cava-portal vein shunt.
- Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation.
- Impact of pretransplant hyponatremia on outcome following liver transplantation.
- Acute kidney injury following liver transplantation: definition and outcome.
- Twenty years' follow-up of portal vein conduits in liver transplantation.
- Post-liver transplant survival in hepatitis C patients is improving over time.
- Transplant center regulations--a mixed blessing? An ASTS Council viewpoint.
- Twenty years of follow-up of aortohepatic conduits in liver transplantation.
- Intraoperative imaging of pancreas transplant allografts using indocyanine green with laser fluorescence.
- Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ...
- Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.
- Survival after liver transplantation: Is racial disparity inevitable?
- Pancreatic islet cell transplantation: update and new developments.
- Use of two expanded-criteria-donor renal allografts in a single patient.
- Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT).
- Combined cardiac and liver transplantation for the treatment of familial amyloidosis.
- Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantat...
- Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience.
- Acute graft-versus-host disease after liver transplantation: role of withdrawal of immunosuppression in therapeutic management.
- Graft-vs-host disease as a complication of lung transplantation.
- Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome.
- Clinical outcomes from hepatic artery stenting in liver transplantation.
- Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observation...
- Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection.
- Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: an alternative for type 1 primary hyperoxaluria.
- Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation.
- Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial.
- Pancreatic islet cell transplantation: a treatment strategy for type I diabetes mellitus.
- Two-stage total hepatectomy and liver transplantation for acute deterioration of chronic liver disease: a new bridge to transplantation.
- Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations.
- The Baylor Regional Transplant Institute: review of a twenty-year experience.
- Liver transplantation and health-related quality of life: scoring differences between men and women.
- Societal reintegration after liver transplantation: findings in alcohol-related and non-alcohol-related transplant recipients.
- The history of organ transplantation in the Baylor Health Care System.
- Pseudohypocalcemia after magnetic resonance imaging with gadolinium in patients with cirrhosis.
- The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation.
- Xanthomas disappear rapidly after liver transplantation for familial hypercholesterolemia.
- Baylor Regional Transplant Institute: an update on liver, kidney, and pancreas transplantation.
- A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation.
- Syndromic incidence of ovarian carcinoma after liver transplantation, with special reference to anteceding breast cancer.
- Unusually high incidence of positive HTLV I/II results among young female organ donors in the peripartum period.
- Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders.
- Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry.
- Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients.
- Hepatitis C and mycophenolate mofetil--a clarification.
- De novo tumors after liver transplantation: a single-institution experience.
- Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantation.
- Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation.
Doctors Specialties
- General Surgery
- Transplant Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Hospital
-
Baylor All Saints Medical Center at Fort Worth -
Baylor University Medical Center
Drug Facts
| NPI NUMBER | 1245260280 | |
| NPPES Provider LastName | KLINTMALM | |
| NPPES Provider FirstName | GORAN | |
| NPPES Provider ZIPCode | 752462003 | |
| NPPES Provider State | TX | |
| Specialty Description | General Surgery | |
| Total Claim Count | 12.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1245260280 |
| Last Name Of The Provider | KLINTMALM |
| First Name Of The Provider | GORAN |
| View All |
Similar Doctors
|
Dr. Steven Camp, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glen D. Hooker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vaishali T. Kent, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John L. Crawford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen Rush, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John H. Smith, MD |
|
|
Dr. Fernando Garcia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Minh Nguyen, MD |
|
|
Dr. Jessica L. Laorden, MD |
|
|
Dr. Nicholas Onaca, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Tariq N. Khan, MD |